Semler Scientific Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Devices
Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
Current Price
$20.33
+0.00%GoodMoat Value
$128.87
533.9% undervaluedProfile
Valuation (TTM)
Market Cap$300.98M
P/E6.23
EV—
P/B1.30
Shares Out14.80M
P/Sales8.14
Revenue$36.96M
EV/EBITDA6.15
Semler Scientific Inc (SMLR) Stock Analysis
Market Cap$300.98M
Current Price$20.33
P/E Ratio6.23
Forward P/E—
PEG Ratio0.15
EPS$5.13
Book Value$15.59
P/B Ratio1.30
SMLR Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use 36.2% FCF growth (CAGR)
Cash vs Debt
Net Cash: 9M
Revenue
21M
FY18
33M
FY19
39M
FY20
53M
FY21
57M
FY22
68M
FY23
56M
FY24
Net Income
5M
FY18
15M
FY19
14M
FY20
17M
FY21
14M
FY22
21M
FY23
41M
FY24
SMLR 52-Week Range
$15.21
$45.97
50-Day MA: $20.31200-Day MA: —
Did you know?
Profit margin of 130.8% — that's well above average.
Semler Scientific Inc (SMLR) Financial Summary
Semler Scientific Inc (SMLR) is a Healthcare company in the Medical Devices industry, listed on NASDAQ. The stock currently trades at $20.33 with a market capitalization of $300.98M.
Key valuation metrics include a P/E ratio of 6.23, price-to-book ratio of 1.30, and EPS of $5.13. The company reports a profit margin of 130.8% and return on equity of 20.9%.
SMLR Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $300.98M |
| P/E Ratio | 6.23 |
| EPS | $5.13 |
| P/B Ratio | 1.30 |
| P/S Ratio | 8.14 |
| EV/EBITDA | 6.15 |
| Profit Margin | 130.8% |
| Return on Equity | 20.9% |
SMLR Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY18 | $21.49M | $5.01M |
| FY19 | $32.77M | $15.08M |
| FY20 | $38.60M | $14.01M |
| FY21 | $53.03M | $17.22M |
| FY22 | $56.69M | $14.32M |
| FY23 | $68.18M | $20.58M |
| FY24 | $56.29M | $40.90M |
Semler Scientific Inc (SMLR) Valuation
Based on GoodMoat's DCF model, Semler Scientific Inc has a fair value estimate of $128.87. At the current price of $20.33, the stock appears 84.2% undervalued relative to our intrinsic value estimate.
SMLR Quality Indicators
Semler Scientific Inc maintains a profit margin of 130.8% and an operating margin of 37.2%. Return on equity stands at 20.9%. The current ratio is 3.59.
About Semler Scientific Inc
Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
SMLR Free Cash Flow
Semler Scientific Inc generated $24.63M in trailing twelve-month free cash flow, representing an FCF yield of 8.18%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
SMLR Shares Outstanding
Semler Scientific Inc has 0.01 billion shares outstanding at a share price of $20.33, giving it a market capitalization of $300.98M.